The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Forest Laboratories Inc (FRX)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Buy Forest Labs (FRX) and get 16% compounded annual return

Sep 04, 2007 05:22 AM GMT
Warren_buffett
Return Risk
-9.39% HIGH
Associate

Fundamental Analysis   Analyst Recommendation  

Forest Labs (FRX) develops and makes branded and generic ethical drug products. It products include Lexapro, a single isomer version of Celexa for the treatment of major depression and generalized anxiety disorder; Namenda, N-methyl-D-aspartate antagonist for the treatment of moderate to severe Alzheimer's disease; Benicar, an angiotensin receptor blocker for the treatment of hypertension, and

FRX:  This call was made on 09/04/07 @ $38.44
Rating:   Positive   $38.44 (09/04/07)
Gain/Loss:   -20.16% in 812 days


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.37% 379
2 Gerald Greene 18.14 +70.70% 209
3 stockmarketfunding.com 17.66 +25.67% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +78.05% 39


POPULAR STOCKS
Symbol Company Name Sentiment
GOOG Google Inc
PG The Procter & Gamble Company
WM Washington Mutual Inc
BAC Bank of America Corp
JNJ Johnson & Johnson
GLD streetTRACKS Gold

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Forest Laboratories Inc (FRX)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
86.0%
Top:
100.0%




Latest Picks by retirerichblog
Symbol SP Sentiment Rating Return Since
TEX Positive -59.92% 08/24/08
GRMN Positive -11.65% 08/24/08
BP Positive +2.96% 08/24/08
GS Positive +7.91% 08/24/08
ACH Positive +27.46% 08/24/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch